These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 25685037)
1. Importance and globalization status of good manufacturing practice (GMP) requirements for pharmaceutical excipients. Abdellah A; Noordin MI; Wan Ismail WA Saudi Pharm J; 2015 Jan; 23(1):9-13. PubMed ID: 25685037 [TBL] [Abstract][Full Text] [Related]
2. An Overview of Pharmaceutical Excipients: Safe or Not Safe? Abrantes CG; Duarte D; Reis CP J Pharm Sci; 2016 Jul; 105(7):2019-26. PubMed ID: 27262205 [TBL] [Abstract][Full Text] [Related]
4. Polyoxylglycerides and glycerides: effects of manufacturing parameters on API stability, excipient functionality and processing. Jannin V; Rodier JD; Musakhanian J Int J Pharm; 2014 May; 466(1-2):109-21. PubMed ID: 24607211 [TBL] [Abstract][Full Text] [Related]
5. The evolution and challenges for the international harmonization of the regulation of pharmaceutical excipients in Taiwan. Chang LC; Kang JJ; Gau CS Regul Toxicol Pharmacol; 2015 Dec; 73(3):947-52. PubMed ID: 26387930 [TBL] [Abstract][Full Text] [Related]
6. Excipient variability and its impact on dosage form functionality. Dave VS; Saoji SD; Raut NA; Haware RV J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249 [TBL] [Abstract][Full Text] [Related]
14. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union. Kroes BH J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408 [TBL] [Abstract][Full Text] [Related]
15. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics. Rayaprolu BM; Strawser JJ; Anyarambhatla G Drug Dev Ind Pharm; 2018 Oct; 44(10):1565-1571. PubMed ID: 29863908 [TBL] [Abstract][Full Text] [Related]
16. [Contributions of the Japanese Pharmacopoeia to the Quality of Generic Pharmaceuticals]. Izutsu KI Yakugaku Zasshi; 2020; 140(6):773-776. PubMed ID: 32475926 [TBL] [Abstract][Full Text] [Related]
17. The safety of pharmaceutical excipients. de Jong HJ Therapie; 1999; 54(1):11-4. PubMed ID: 10216416 [TBL] [Abstract][Full Text] [Related]
18. Good manufacturing practice: the role of local manufacturers and competent authorities. Tomić S; Filipović Sučić A; Ilić Martinac A Arh Hig Rada Toksikol; 2010 Dec; 61(4):425-36. PubMed ID: 21183434 [TBL] [Abstract][Full Text] [Related]
19. Direct compression high functionality excipient using coprocessing technique: a brief review. Mirani AG; Patankar SP; Borole VS; Pawar AS; Kadam VJ Curr Drug Deliv; 2011 Jul; 8(4):426-35. PubMed ID: 21235470 [TBL] [Abstract][Full Text] [Related]
20. Decision Support for Excipient Risk Assessment in Pharmaceutical Manufacturing. Bejarano A; Hewa Nadungodage C; Wang F; Catlin AC; Hoag SW AAPS PharmSciTech; 2019 Jun; 20(6):223. PubMed ID: 31214878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]